Analyst Research
| Report Title | Price |
|---|---|
|
Trading Report for (SNY). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Market Edge
|
$10.00
|
|
Provider: Finlabo SIM Spa
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Sanofi SA Inaugurates Lantus SoloSTAR Pen Assembly Plant in its Beijing Facility
Sanofi SA announced the inauguration of a new assembling and packaging line to produce its flagship pre-filled insulin injection pen Lantus SoloSTAR at its Beijing plant located at the Beijing Economic-Technological Development Area (BDA). Presiding over the inauguration ceremony, Christopher A. Viehbacher, Chief Executive Officer of Sanofi, announced the second phase of the USD 90 million project to install a high-tech cartridge aseptic production line. With a designed capacity of 48 million units per year, the facility is expected to help fulfill the needs of people with diabetes and ultimately improve the standard of diabetes care in China.
Latest Developments for Sanofi SA
- Sanofi SA Wins Japanese Government's Approval for Lyxumia Drug-Reuters
- Sanofi SA to Cut 207 Research Posts in France; Updates on Toulouse Site-Agence France Press
- Sanofi SA Announces Phase 3 Results for Investigational New Insulin U300
- Sanofi SA and Takeda Pharmaceutical Co Ltd Sets up Joint Venture- SeeNews
Latest Key Developments in Pharmaceuticals
- Biogen Idec Inc And Swedish Orphan Biovitrum AB Presents New Data From Phase 3 Study Of Long-Lasting Hemophilia Factor Candidate ALPROLIX
- Medicines Co Announces Positive Results For Solo II Trial Of Oritavancin In Treatment Of Acute Bacterial Skin And Skin Structure Infections
- OHKI CO LTD Announces Concern of Uncollectible or Delayed Receivables
- CKD Bio Announces Resignation of Co-CEO
- Share this
- Link this
- Digg this
Follow Reuters